A single dose of a new nicotine vaccine could provide lifetime protection from the pleasurable effects of nicotine, helping existing smokers quit for good and preventing those that haven't yet smoked from becoming addicted (Photo: Shutterstock)
Researchers at Weill Cornell Medical College have developed a vaccine that could help existing smokers quit for good and prevent those yet to try cigarettes from ever becoming addicted. The vaccine turns the recipient’s kidney into a factory continuously churning out antibodies that clear the bloodstream of nicotine before it has a chance to reach the brain and deliver it’s addictive rush. Unlike previously tested nicotine vaccines that only last a few weeks, the effects of a single dose of this new vaccine should last a lifetime.
Other Images from this Gallery